These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2821337)

  • 1. Reversal of the actions of morphine on mesocortical dopamine metabolism in the rat by the kappa agonist MR-2034: tentative mu-2 opioid control of mesocortical dopaminergic projections.
    Kim HS; Iyengar S; Wood PL
    Life Sci; 1987 Oct; 41(14):1711-5. PubMed ID: 2821337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opiate actions on mesocortical dopamine metabolism in the rat.
    Kim HS; Iyengar S; Wood PL
    Life Sci; 1986 Nov; 39(21):2033-6. PubMed ID: 3784768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphine stimulation of mesolimbic and mesocortical but not nigrostriatal dopamine release in the rat as reflected by changes in 3-methoxytyramine levels.
    Wood PL; Rao TS
    Neuropharmacology; 1991 Apr; 30(4):399-401. PubMed ID: 1852270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu opiate isoreceptors: differentiation with kappa agonists.
    Wood PL; Richard JW; Thakur M
    Life Sci; 1982 Nov 15-22; 31(20-21):2313-7. PubMed ID: 6131359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex.
    Heijna MH; Padt M; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    Eur J Pharmacol; 1990 Jun; 181(3):267-78. PubMed ID: 2166675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agonist action of the agonist/antagonist analgesic butorphanol on dopamine metabolism in the nucleus accumbens of the rat.
    Iyengar S; Kim HS; Wood PL
    Neurosci Lett; 1987 Jun; 77(2):226-30. PubMed ID: 3601233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agonist/antagonist analgesics and nigrostriatal dopamine metabolism in the rat: evidence for receptor dualism.
    Wood PL; McQuade P; Richard JW; Thakur M
    Life Sci; 1983; 33 Suppl 1():759-62. PubMed ID: 6319927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The endogenous kappa agonist, dynorphin(1-13), does not alter basal or morphine-stimulated dopamine metabolism in the nigrostriatal pathway of the rat.
    Wood PL; Kim HS; Cosi C; Iyengar S
    Neuropharmacology; 1987 Nov; 26(11):1585-8. PubMed ID: 2893309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-tetrahydrofurfuryl benzomorphans: comparison of a kappa and an agonist/antagonist analgesic.
    Wood PL
    Neuropeptides; 1985 Feb; 5(4-6):323-6. PubMed ID: 2987733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid kappa receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. I. Effects of opioid kappa receptor agonists bremazocine and U-50,488 on secretion of PRL and GH: comparison with morphine.
    Krulich L; Koenig JI; Conway S; McCann SM; Mayfield MA
    Neuroendocrinology; 1986; 42(1):75-81. PubMed ID: 3001565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesocortical dopamine neurons: rapid transmitter turnover compared to other brain catecholamine systems.
    Bannon MJ; Bunney EB; Roth RH
    Brain Res; 1981 Aug; 218(1-2):376-82. PubMed ID: 7272743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CRF in the release of ACTH by opiate agonists and antagonists in rats.
    Nikolarakis K; Pfeiffer A; Stalla GK; Herz A
    Brain Res; 1987 Sep; 421(1-2):373-6. PubMed ID: 2825911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific mu 2 opioid isoreceptor regulation of nigrostriatal neurons: in vivo evidence with naloxonazine.
    Wood PL; Pasternak GW
    Neurosci Lett; 1983 Jun; 37(3):291-3. PubMed ID: 6310456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response.
    Deutch AY; Tam SY; Freeman AS; Bowers MB; Roth RH
    Eur J Pharmacol; 1987 Feb; 134(3):257-64. PubMed ID: 3569414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain.
    Mulder AH; Burger DM; Wardeh G; Hogenboom F; Frankhuyzen AL
    Br J Pharmacol; 1991 Feb; 102(2):518-22. PubMed ID: 1673074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex.
    Izenwasser S; Werling LL; Cox BM
    Brain Res; 1990 Jun; 520(1-2):303-9. PubMed ID: 2145054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cortical and striatal mu-opioid receptors are altered by gonadal hormone treatment but not by prenatal morphine exposure in adult male and female rats.
    Slamberová R; Rimanóczy A; Schindler CJ; Vathy I
    Brain Res Bull; 2003 Nov; 62(1):47-53. PubMed ID: 14596891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of the selective kappa-opioid agonist MR 2034 on the guinea-pig ileum.
    Coupar JM; Quinn MJ
    J Pharm Pharmacol; 1988 May; 40(5):378-80. PubMed ID: 2899640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphine and nigrostriatal function in the rat and mouse: the role of nigral and striatal opiate receptors.
    Wood PL; Richard JW
    Neuropharmacology; 1982 Dec; 21(12):1305-10. PubMed ID: 6296716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.